Therefore, the AR antagonism strategy has been highly efficient, as it can also affect the associated metabolic network; however, in the case of androgen-resistant PCa, androgen-independent AR activation takes place to bypass the AR requirement and become a more aggressive AR-indifferent carcinoma [165]. Here, AR is linked to carcinoma.